Yukio Kobayashi

17PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jun 09, 2021
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.

Tomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima

|Oct 06, 2020
Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.

Takafumi Shichijo, Dai Maruyama, Nobuhiko Yamauchi

|Sep 04, 2020
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.

Hitoshi Minamiguchi, Hiroyuki Fujita, Yoshiko Atsuta

|Jan 24, 2020
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.

Hitoshi Kiyoi, Joan D Morris, Iekuni Oh

|Mar 30, 2019
Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results.

Kosuke Toyoda, Akiko Miyagi Maeshima, Junko Nomoto

Pageof 3

Frequent Collaborators

4 joint publications

Shigeki Ohtake

2 joint publications

Shinichi Makita

2 joint publications

Hitoshi Kiyoi

2 joint publications

Dai Maruyama